Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
New center helps meet growing need for pediatric care in our community Families in northern Delaware and surrounding areas have a new option for pediatric care. Today ChristianaCare opened a new 14-bed Pediatric Care Center that provides 24/7 combined short-stay inpatient and emergency care for children and teens. The new center is located on the first floor of the Center for Women’s & Children’s Health on ChristianaCare’s Newark Campus. “This new facility is an exciting step in our continued journey to create the absolute best care for children and families in our community,” said David Paul, M.D., chair of the Department of Pediatrics. “The Pediatric Care Center will significantly improve access to care for children, enhance the patient experience and address the needs of families who want high-quality care in a child-friendly environment.” The 24-hour Pediatric Care Center will be able to evaluate and manage 90% of the pediatric cases currently seen in the Christiana Hospital Emergency Department. The center expects to care for an estimated 6,300 patients the first year, with volume projected to grow 5% each year. The Pediatric Care Center also provides expert care to children and adolescents with behavioral health emergency needs and appropriate referral sources for follow-up care. “Our new Pediatric Care Center makes it easier than ever for families and children to receive excellent care when they need it, in a special space designed just for them,” said Sharon Kurfuerst, Ed.D., OTR/L, FACHE, system chief operating officer at ChristianaCare and President, Union Hospital. “The center will care for the special needs of pediatric patients, making it convenient for them to receive dedicated, expert resources for hospital-based, non-trauma emergency and inpatient care all in one location.” The 8,400 square-foot facility provides 14 beds for emergency and short-stay inpatient and observation care. “We offer 24/7 pediatric emergency care 365 days a year,” said Megan Mickley, M.D., MBA, FAAP, FACEP, medical director, who is board certified in Pediatrics and Pediatric Emergency Medicine and fellowship-trained in Pediatric Emergency Medicine and Emergency Ultrasound. “The Pediatric Care Center team is a diverse, multidisciplinary group led by pediatric physicians trained in a variety of backgrounds, including emergency medicine and hospital medicine,” she said. “Our goals are not only to provide exceptional quality of care for children, but also to improve access to and expand pediatric care services for our neighbors. We look forward to being a trusted partner for pediatric care in our community.” About the Center for Women’s & Children’s Health The Center for Women’s & Children’s Health, which opened in a state-of-the-art facility in 2020 on ChristianaCare’s Newark campus, represents a new standard of care for our community. It is the region’s only National Community Center of Excellence in Women’s Health and offers innovative, patient-centered care for mothers, babies and families. The center provides private rooms for mothers and families after delivery and is one of the only hospitals in the United States to provide couplet care in the Neonatal Intensive Care Unit, keeping mother and baby together even if they both require medical care.
Aston University to launch Aston Centre for Applied Linguistics
The Centre is an interdisciplinary, multilingual group of researchers made up of academic staff and research students It aims to build on Aston University’s longstanding expertise in research into language education, languages, and applied linguistics The hybrid launch event will take place at the University on 14 September Aston University is launching a new research centre within its College of Business and Social Sciences. The Aston Centre for Applied Linguistics (ACAL), formerly known as the Centre for Language Research at Aston (CLaRA), aims to build on Aston University’s longstanding expertise in research into language education, languages, and applied linguistics by promoting interdisciplinary collaboration and establishing national and international networks and partnerships. ACAL is an interdisciplinary, multilingual group of researchers – academic staff and research students – who work in the field of language and language education research. The Centre will officially be launched through a hybrid event at the University on 14 September 2022. There will be talks by Aston University’s Dr Lucia Busso & Dr Marton Petyko, Dr Marcello Giovanelli, Dr Megan Mansworth and Dr Emmanuelle Labeau as well as guest lectures from Professor Zhu Hua (IOE faculty of education and society, UCL) and Terry Lamb (professor of languages and interdisciplinary pedagogy, University of Westminster and Aston University language graduate). The event will conclude with a celebration of the major publications of ACAL members in 2021-22. Dr Emmanuelle Labeau, director of ACAL, said: “Language actually is all around us: we use it to articulate all our human activities. “Languages actually are all around us: over 100 languages are spoken in Birmingham “My recent AHRC-funded project BRUM (Birmingham Research for Upholding Multilingualism) has shown that research in language(s) is needed in local schools, businesses, public services and culture. “ACAL wants to put the ‘applied’ into linguistics to serve the University, the city, region and beyond. Our researchers are a great asset to the University’s ambitions, and we cannot wait informing and helping shape the Aston University 2030 Strategy.”
With inflation rampant, everyone is concerned about money and the economy -- not just the prices on everyday goods and services, but their investments as well. The situation has people on edge. Rick Franza, dean of Hull College of Business at Augusta University, said there are differences between the economy and the markets. “Part of that is in the economy, we worry about now and the stock market is more forward-looking, so there’s always some disconnect between the financial markets and the economic reality," Franza said. "The disconnect seems to be worse than ever. There’s less correlation between the economic news and where the stock market goes.” “We used to think that a good jobs report would make a good economy, and typically it does, but in the last couple of months when the jobs report was good, the market has tanked. People are reading it as the strong job market means inflation is not under control." Franza indicated there is a fear factor when it comes to the stock market and its steady decline over the last nine months. Younger investors in the market haven’t seen many bad times, so they are fearful. He also said people nearing retirement are fleeing the market as well. When it comes to the drop in the stock market, it affects anyone who has investments. “Most of us have some kind of investments, especially in retirement accounts,” Franza added. Inflation though, has been the dominating factor in the market right now. "The impact of inflation will be more on small businesses. The large businesses will find a way to weather the storm. If inflation continues and companies can’t be profitable, they’ll start laying off people. Then we’ll have a recession, which will reduce inflation.” It could also have a rippling affect on consumer choices and ultimately costs. “If more companies go out of business, it’ll give us fewer choices, which means the supply chain will be restricted. Then, you’ll pay higher prices because of fewer options. In the long run, if the Fed sticks to its plan to keep raising rates, it will reduce inflation.” If you're looking to know more about this important topic, then let us help. Franza is available to speak with media about trending issues like inflation, small business and the economy – simply click on his icon now to arrange an interview today.
UConn insect expert David Wagner on the troubling decline of the mayfly
One of the world's oldest flying insects is in trouble. Mayflies are in serious decline and, after 300 million years in existence, their dwindling population should be an alarm bell for all of us. More than just a bug with a short life span flying masterfully near creeks, rivers, and ponds, the mayfly plays a serious role in local ecosystems and the environment at large. A key component in the food chain, the mayfly nymph feeds off of algae, plants, and rotting leaves, cleaning up nature's mess while growing large enough to become a meal itself -- for fish, amphibians, lizards, birds, and even humans. Without mayflies, the ripple effect upwards could mean calamity for the planet. In a recent Washington Post Magazine deep-dive, UConn insect expert David Wagner offered his perspective on the on the plight of the mayfly: I reached out to David Wagner, a biologist and lepidopterist at the University of Connecticut, for context, thinking that perhaps the problems were isolated or overblown. He has studied insects for decades and reviewed numerous scientific studies about them from around the globe. He did not provide much comfort. There’s a growing body of research suggesting that the world is in the midst of its sixth mass extinction, he said. The losses of all kinds of creatures appear to be driven by climate change, habitat degradation, pollution and other ecological stressors. In a paper for the Proceedings of the National Academy of Sciences last year, “Insect Decline in the Anthropocene: Death by a Thousand Cuts,” Wagner and several other scientists delivered a stark warning about the disappearance of insects. The report did not focus on mayflies, but Wagner told me they are among the most vulnerable of the world’s insects because of their need for clean, well-oxygenated water. “Mayflies are reliable ‘canaries in the coal mines’ for freshwater systems,” he explained. “And their future prospects, especially in areas that are drying or warming, are bleak.” September 19 - Washington Post Magazine Dr. David Wagner is an expert in caterpillars, butterflies, moths, and insect conservation, and he's commented extensively on the current decline of insects worldwide. Click his icon to arrange an interview today.
25th Anniversary African American Art Song Alliance Conference
25th Anniversary African American Art Song Alliance Conference Organized by Dr. Darryl Taylor October 13 - October 16, 2022 The African American Art Song Alliance, founded by Professor of Music Dr. Darryl Taylor in 1997, is one of the nation’s leading advocacy organizations, representing Black composers of Western classical art songs. Its quinquennial conference is unique and inspirational for scholars and performers of this music. Learn more about the conference and its events on the website at music.arts.uci.edu. Come be part of this community of like-minded supporters! The Alliance remains focused on maintaining accessibility for the audience it serves and the larger population. They have made registration free and open to the public for the conference and its events. To learn more about the African American Art Song Alliance, visit their website at https://artsongalliance.org To speak to Dr. Taylor about the conference, contact Tom Vasich at 1-949-285-6455 or tmvasich@uci.edu.
Tokyo International Conference on African Development
Aston University co-hosted parts of the eighth Tokyo International Conference on African Development (TICAD8). There was a total of six talks hosted by the University, five of which are available to catch up on below. TICAD8 is the eighth event of TICAD, having been initiated by Japan in 1932. The conference brings together international organisations and business representatives from African countries and Japan to promote the digitalisation of African nations to keep pace with other leading economies. Cyber security and data privacy were two of the main topics up for discussion as well as central bank digital currencies (CBDC). CBDC is a government-issued fiat currency, that is, a currency not backed by a commodity such as gold. The use of an ideal CBDC will eliminate over 100,000 armoured cars carrying cash for ATM machines all over the world, reducing CO² emissions. Experts say transitioning to fiat currency requires the highest level of cyber security. The digitalisation of the healthcare sector in Africa Professor Georg Holländer of Oxford University speaks with Aston University visiting professor - and GVE founder - Koji Fusa. The discussion focuses on the benefits of an electronic health record for both an individual and the health care provider but will also relate these benefits to issues of public health and research. The technical challenges of providing the conventional infrastructure to establish health care records will be touched on with a focus placed on data security. Reasons will be pointed out that impede the uptake of electronic health records, especially in low and middle income countries, and possible solutions are presented to overcome this problem. CBDC and private sector digital currency will facilitate the digitalisation of nations of African countries CBDC will require the highest security and privacy protection. Professor Koji Fusa, Cyber Security Innovation Centre, Aston University, CEO of GVE Ltd discusses the benefits of a comprehensive digitalisation of fiat currency. This will become a powerful digital infrastructure which could expand into other areas like healthcare. The cyber security issue pointed by the US NIST in 2016 could be solved by having a different set of systems which could reduce the risks being presented by international hacking groups having quantum computers in the future. The World Bank's support for digitalisation of Africa Takashi Miyahara, the Executive Director of the World Bank Group, presents this talk in his personal capacity. Mr. Miyahara introduces the World Bank’s contribution to date, and Japan’s collaboration with the Bank, for digital development of Africa. Mr. Miyahara worked for the Ministry of Finance of Japan since 1986 before he took the current position in January 2021. Vaccine and climate transition in Africa René Karsenti, senior adviser and honorary president of the International Capital Market Association (ICMA), former board chair of the International Finance Facility for Immunisation (IFFIm), honorary director general of the European Investment Bank (EIB) and member of the Global Advisory Board of GVE Ltd, talks to Aston University's Koji Fusa about vaccine and climate transition in Africa: two major challenges, lessons from innovative ESG financing and future endeavours. Health and vaccine finance, climate transition and sustainable finance have sparked a revolution in thinking about innovative solutions leading to implementing successfully new humanitarian finance such as IFFIm, financing GAVI, the Vaccine Alliance, as well as other new ESG investments to achieve a positive impact. He says: "Needs remain huge in Africa. "We are now at a decisive moment in such ESG investments. We have evolved in a few years from a situation where investors knew - and cared - little about what their investments were supporting, to one where purpose matters more than ever. "But only by recognizing the urgency for action particularly in Africa and the power of ESG investment, collaboration, technology and innovation would get us there." Cyber security, financial integrity and developments Professor George Feiger is the executive dean of the College of Business and Social Sciences at Aston University. He suggests truly secure data transfer has the capability to transform more than medicine and finance in the efficiency sense and also holds out the promise of helping to clean up the even more consequential problem of looting of the state.
Advantage Ukraine? A surprising surge has Russia in retreat
The war in Ukraine has taken a surprising turn. A hard surge in the northeast of the country has seen Ukraine soldiers reclaiming lost ground and in some cases, even pushing Russian troops back to the border. It's a David and Goliath scenario, and at the moment, Ukraine finally seems to have the upper hand over the larger and more equipped Russian forces that have been clawing away at the country since February. There's been an enormous amount of media attention and reporters are looking to experts for perspective, opinion and explanation. “It seems to be a complete failure of logistics and strategy tactics on the Russian side," said Dr. Craig Albert, director of the Master of Arts in Intelligence and Security Studies at Augusta University. "Everything is just falling apart; their lines are collapsing. Troops are running and leaving behind all their ammunition, leaving vehicles, leaving weapons. That’s just astonishing to me that it is such a disorganized kind of retreat. Russia can use all their propaganda and say they are retrenching elsewhere and trying to solidify their forces further east and further south, but it’s a disorganized retreat and they’re losing lots of numbers but leaving all their equipment to the Ukrainians." Albert can explain what could happen next in Ukraine, as there are several possible scenarios and outcomes in the long and short term of this war. And if you’re a journalist looking to know more about what lies ahead as the war between Ukraine and Russia continues and how it may impact the United States, then let us help with your questions and coverage. Albert is director of the Master of Arts in Intelligence and Security Studies at Augusta University. He is a leading expert on war, terrorism and American politics. This is an important national and international issue. Albert is available to speak with media – simply click on his name to arrange an interview today.
Manuka honey could help to clear deadly drug-resistant lung infection – research
• Scientists develop a potential nebulisation treatment using manuka honey to clear a drug resistant lung infection that can be fatal in cystic fibrosis patients • Aston University researchers combined the antibiotic amikacin with manuka honey as a novel treatment for Mycobacterium abscessus • Using the manuka honey combination resulted in an eight-fold reduction in the dosage of the antibiotic A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists at Aston University to treat a potentially lethal lung infection and greatly reduce side effects of one of the current drugs used for its treatment. The findings, which are published in the journal Microbiology, show that the scientists in the Mycobacterial Research Group in the College of Health and Life Sciences at Aston University were able to combine manuka honey and the drug amikacin in a lab-based nebulisation formulation to treat the harmful bacterial lung infection Mycobacterium abscessus. Manuka honey is long known to have wide ranging medicinal properties, but more recently has been identified for its broad spectrum antimicrobial activity. Now scientists have found that manuka honey has the potential to kill a number of drug resistant bacterial infections such as Mycobacterium abscessus – which usually affects patients with cystic fibrosis (CF) or bronchiectasis. According to the Cystic Fibrosis Trust, CF is a genetic condition affecting around 10,800 people - one in every 2,500 babies born in the UK -and there are more than 100,000 people with the condition worldwide. The NHS defines bronchiectasis as a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection.. In the study, the researchers used samples of the bacteria Mycobacterium abscessus taken from 16 infected CF patients. They then tested the antibiotic amikacin, combined with manuka honey, to discover what dosage was required to kill the bacteria. As part of the study the team used a lab-based lung model and nebuliser - a device that produces a fine spray of liquid often used for inhaling a medicinal drug. By nebulising manuka honey and amikacin together, it was found they could improve bacterial clearance, even when using lower doses of amikacin, which would result in less life-changing side-effects to the patient. In the UK, of the 10,800 people living with CF, Mycobacterium abscessus infects 13% of all patients with the condition. This new approach is advantageous not only because it has the potential to kill off a highly drug resistant infection, but because of the reduced side effects, benefitting quality of life and greatly improving survival chances for infected CF patients. Mycobacterium abscessus is a bacterial pathogen from the same family that causes tuberculosis, but this bug differs by causing serious lung infections in people (particularly children) with pre-existing lung conditions, such as CF and bronchiectasis, as well as causing skin and soft tissue infections. The bacteria is also highly drug resistant. Currently, patients are given a cocktail of antibiotics, consisting of 12 months or more of antimicrobial chemotherapy and often doesn’t result in a cure. The dosage of amikacin usually used on a patient to kill the infection is 16 micrograms per millilitre. But the researchers found that the new combination using manuka honey, required a dosage of just 2 micrograms per millitre of amikacin - resulting in a one eighth reduction in the dosage of the drug. Until now Mycobacterium abscessus has been virtually impossible to eradicate in people with cystic fibrosis. It can also be deadly if the patient requires a lung transplant because they are not eligible for surgery if the infection is present. Commenting on their findings, lead author and PhD researcher Victoria Nolan said: "So far treatment of Mycobacterium abscessus pulmonary infections can be problematic due to its drug resistant nature. The variety of antibiotics required to combat infection result in severe side effects. "However, the use of this potential treatment combining amikacin and manuka honey shows great promise as an improved therapy for these terrible pulmonary infections. “There is a need for better treatment outcomes and in the future we hope that this potential treatment can be tested further.” Dr Jonathan Cox, senior lecturer in microbiology, Aston University said: “By combining a totally natural ingredient such as manuka honey with amikacin, one of the most important yet toxic drugs used for treating Mycobacterium abscessus, we have found a way to potentially kill off these bacteria with eight times less drug than before. This has the potential to significantly reduce amikacin-associated hearing loss and greatly improve the quality of life of so many patients – particularly those with cystic fibrosis. “I am delighted with the outcome of this research because it paves the way for future experiments and we hope that with funding we can move towards clinical trials that could result in a change in strategy for the treatment of this debilitating infection.” Dr Peter Cotgreave, chief executive of the Microbiology Society said: "The Microbiology Society is proud to support the scientific community as it explores innovative solutions to overcome the growing global challenge of antimicrobial resistance. This study demonstrates one of many ways in which microbiologists are pioneering new methods to tackle drug-resistant infections, by incorporating natural products, like manuka honey, into existing therapies." For more information about the School of Biosciences, please visit our website.
Bivalent Boosters are Here: Our Expert Explains What You Need to Know
Updated COVID-10 booster shots are rolling out across the United States, and these new bivalent formulations target the omicron BA.4 and BA.5 subvariants that have become the dominant circulating strains as well as the original form of the coronavirus. UConn Health's Dr. David Banach, an infectious diseases physician and hospital epidemiologist, spoke with UConn Today about the latest CDC vaccination guidelines and the significance of these updated boosters: What’s the difference between the monovalent and bivalent vaccines? The monovalent vaccines are the ones that have been available thus far. They contain a small piece of the mRNA component of the virus based on the original SARS-CoV-2 virus, sometimes termed as the “ancestral strain,” and are designed to generate an immune response to that original virus. We’ve seen with the omicron variant — and specifically with the BA.4 and BA.5 subvariants, which have appeared most recently — the virus has changed. The bivalent vaccine contains both the portion of the original ancestral virus mRNA as well as a portion of mRNA that is specific for the BA.4 and BA.5 subvariants that have been circulating most recently. The hope is, by more specifically targeting the most recent subvariants, the bivalent boosters will reduce the impact of COVID both on individuals who received them as well as the population. Conceptually it’s analogous to what has been done with the influenza vaccine. The technology’s a little different but it’s based on the same idea. It’s targeted against both the original strain and the BA.4 and BA.5 subvariants of omicron. What becomes of the monovalent vaccine? At this time the vaccination program will be a primary vaccine series with the original monovalent vaccine and booster doses using the bivalent vaccine. Why wouldn’t we just start people with the bivalent vaccine? Data showed the monovalent vaccine upfront provides that high level of protection. The bivalent vaccine has not been evaluated as a primary vaccine candidate, so we don’t have the data to support its use in that context. That’s how it was originally designed, to be a booster. Dr. Banach is a leading voice on the fight against the COVID-19 virus, and he's available to speak with the media. Click on his icon to arrange an interview today.
/cloudfront-us-east-1.images.arcpublishing.com/gray/GEHAY7MEYRD4NHFWOELCD7EWLM.jpg)
FBI data shows murders are up, and our experts are ready to help with your coverage
FBI data shows murder rates are up, with the latest figures showing a staggering 21,570 murders happening nationwide in 2020. Dr. Kim Davies teaches a sociology of murder course at Augusta University and was recently interviewed on the topic by a local CBS affiliate. Davies has developed the course to help educate students and get them thinking about ways they can bring awareness to the violent crime problem. Students put a tick on the sidewalk in chalk to represent every murder to offer a better understanding of the number of families affected. “If I put that number on the board, it looks like a big number," said Davies. "But nobody really knows what that is. If we tick every mark and we say, ‘Look, that’s a victim,’ it means more to the students.” Davies also reiterates that even though this current number is probably the highest it’s ever been since she's been offering this class, it's not at an all-time high. "Murder was higher in the '90s when I was in grad school, but it’s been going down, down, down. Hopefully it’s not a trend where we continue up, but we’re back up.” If you’re a journalist covering true crime or any other aspect of this topic, then let us help with your stories. Davies is a sociologically trained criminologist with academic focus is on homicide and violence. Her most recent book, The Murder Book: Understanding Homicide Today, explores topics such as the increase in mass murders, the change in Stand Your Ground laws across the country and police shootings as it relates to the Black Lives Matter movement. Davies is available to speak with media about this subject – simply click on her icon now to arrange an interview today.
